A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and vaccination is critical for preventing further spread or resurgence of the outbreak. Inactivated vaccines made from whole inactivated SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Lidan, Sun, Jingmiao, Wang, Yan, Tan, Danny, Cao, Zhongkai, Gao, Langping, Guan, Yuelin, Jia, Xiuwei, Mao, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302808/
https://www.ncbi.nlm.nih.gov/pubmed/37376434
http://dx.doi.org/10.3390/vaccines11061045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302808/
https://www.ncbi.nlm.nih.gov/pubmed/37376434
http://dx.doi.org/10.3390/vaccines11061045

Ejemplares similares